GabrielAlejandroBien-WillnerMD

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Chief Medical Officer and MolDX Program Director, Palmetto GBA

Dr. Bien-Willner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
26797 Hanna Rd
Bldg 4D1
Oak Ridge North, TX 77385
Phone+1 832-687-8555

Washington University/B-JH/SLCH ConsortiumFellowship, Molecular Genetic Pathology, 2011 - 2012
Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 2008 - 2011
Baylor College of MedicineClass of 2008

Stowell-Orbison Award US and Canada Association of Pathologists, 2011
Young Investigator Award Association of Molecular Pathology, 2012
CAP Foundation Scholar CAP Foundation, 2012
Stowell-Orbison Award, Certificate of Merit US and Canada Association of Pathologists, 2012
Join now to see all

PubMed

152 citations
A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC
Michael J. Schell, Mingli Yang, Jamie K. Teer, Fang Yin Lo, Anup Madan
Nature Communications. 2016-06-15
5 citations
Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors
Gabriel A. Bien-Willner, Robi D. Mitra
Acta Neuropathologica Communications. 2014-07-17
10 citations
Genetic variation in MKL2 and decreased downstream PCTAIRE1 expression in extreme, fatal primary human microcephaly
Enrique Ramos, G.A. Bien‐Willner, J. Li, Andrew E. O. Hughes, Joseph C. Giacalone
Clinical Genetics. 2014-05-01

Journal Articles

Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors
Bien-Willner GA, Mitra RD, Acta Neuropathol Commun, 7/17/2014
Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement
Bien-Willner, GA, López-Terrada D, Bhattacharjee MB, Patel KU, Stankiewicz P, Lupski JR, Pfeifer JR, Perry A, Neuro-Oncology, 3/13/2012

Lectures

Analysis of use of a molecular reporting and treatment decision support tool in more than 1300 cancer cases.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Multidimensional Biomarkers & Machine Learning Based Approaches for Precision MedicineOctober 21st, 2019
Community Hospitals Can Do Precision Medicine Too - Here's HowMay 18th, 2018